Sang Y. Kim

Seocho, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

CSTF2-mediated 3'UTR shortening drives oncogenic activation of GPC3 in hepatocellular carcinoma.

CSTF2-mediated 3'UTR shortening drives oncogenic activation of GPC3 in hepatocellular carcinoma.

Journal: Oncogene

Published: March 22, 2026

Diagnostic accuracy of serum biomarkers MMP11 and SPP1 in non-small cell lung cancer: an analysis of sensitivity, specificity, and area under the curve.

Diagnostic accuracy of serum biomarkers MMP11 and SPP1 in non-small cell lung cancer: an analysis of sensitivity, specificity, and area under the curve.

Journal: Translational lung cancer research

Published: November 11, 2024

Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma.

Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma.

Journal: Experimental & molecular medicine

Published: October 16, 2024

The roles and mechanisms of coding and noncoding RNA variations in cancer.

The roles and mechanisms of coding and noncoding RNA variations in cancer.

Journal: Experimental & molecular medicine

Published: December 19, 2023

ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer.

ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer.

Journal: Experimental & molecular medicine

Published: August 25, 2022

Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma.

Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma.

Journal: Journal of clinical medicine

Published: March 04, 2022

ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB.

ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB.

Journal: Cell death and differentiation

Published: May 11, 2021

SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.

SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.

Journal: Oncogene

Published: November 05, 2020

HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.

HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: November 22, 2018

MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.

MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.

Journal: The Journal of pathology

Published: May 24, 2017

Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.

Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.

Journal: Hepatology (Baltimore, Md.)

Published: May 22, 2017

T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma.

T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma.

Journal: Experimental & molecular medicine

Published: April 21, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026